BSEBrawn Biotech LtdMinimalNeutral
Announced Sat, 30 May · 16:20 IST

BSE Intimation for Non-Applicability of Annual Secretarial Compliance Report under Regulation 24A

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹20.75
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+1.4+5.3-5.1
Up moveDown movePending
AI summary

Brawn Biotech Ltd has informed BSE that the company is exempt from filing the Annual Secretarial Compliance Report under SEBI Regulation 24A. The exemption applies because the company's paid-up share capital is Rs. 3,00,03,000 (below the Rs. 10 crore threshold) and its net worth as of March 31, 2026 was Rs. 4,32,43,720 (below the Rs. 25 crore threshold). The company falls under Regulation 15(2) of SEBI (LODR) Regulations, 2015, which exempts smaller companies from this additional reporting requirement. The intimation was signed by Priyanka Sharma, Company Secretary & Compliance Officer, on May 30, 2026.

Likely market impact

This is a routine compliance filing confirming the company's small-cap status and exemption from certain SEBI reporting requirements. It has no direct impact on shareholder value or stock performance.